Pavia, Italy

Franco Cristiani

This inventor holds 1 USPTO granted patent. Top assignee: Gruppo Lepetit. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franco Cristiani. Retrieved from https://idiyas.com/inventor/franco-cristiani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franco Cristiani: Innovator in Cardiovascular Compounds

Introduction

Franco Cristiani is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with cardiovascular activity. His work has implications for the treatment of coronary conditions.

Latest Patents

Franco Cristiani holds a patent for a compound titled "2-(Aryl)-3-(dimethylamino)butyl-3,4,5-trimethoxybenzoates." This patent describes crystalline solids or liquids that possess two asymmetry centers and can be obtained in stereoisomeric forms. The compounds exhibit cardiovascular activity as coronary dilators and can be synthesized through specific chemical reactions involving α-arylcrotonates and amines.

Career Highlights

Cristiani is associated with Gruppo Lepetit, where he has been instrumental in advancing pharmaceutical innovations. His expertise in organic chemistry and pharmacology has led to the development of novel compounds that can potentially improve cardiovascular health.

Collaborations

Franco Cristiani collaborates with Elvio Bellasio, contributing to the research and development of new pharmaceutical products. Their partnership enhances the innovative capacity of their projects.

Conclusion

Franco Cristiani's work in the field of cardiovascular compounds showcases his dedication to advancing medical science. His patent reflects a significant step forward in the development of effective treatments for coronary conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…